Julius S
Compr Ther. 1980 Mar;6(3):43-8.
Patients with borderline hypertension are at a higher risk to develop sustained hypertension and its sequelae, higher cardiovascular morbidity and mortality. However, this excess risk is not overwhelming. Aggressive antihypertensive medication for all patients with borderline hypertension is not warranted. Only patients who are at highest risk for hypertension and its complications should be given small doses of antihypertensive monotherapy. The objective of the treatment is to lower blood pressure without side effects. Patients who are not chosen for treatment must be continuously managed. The management includes following the blood pressure trends, dietary sodium restriction, and control of overweight.
临界高血压患者发展为持续性高血压及其后遗症、心血管发病率和死亡率更高。然而,这种额外风险并不十分严重。对所有临界高血压患者进行积极的抗高血压药物治疗是没有必要的。只有那些高血压及其并发症风险最高的患者才应给予小剂量的单一抗高血压治疗。治疗的目标是在无副作用的情况下降低血压。未被选择进行治疗的患者必须持续进行管理。管理措施包括跟踪血压趋势、限制饮食中的钠摄入以及控制超重。